Source: GENETIC LITERACY PROJECT, 4/27/18


In one of the final actions of the outgoing Barack Obama administration, the Food and Drug Administration announced it would regulate CRISPR technology as a drug. CRISPR edits DNA, not adding genes from other organisms, but rather using genes already present in an animal or plant. The new rule will slow down approval of gene editing techniques in livestock and increase the cost of receiving approval. Regulating CRISPR as a drug is a body blow to researchers all across the U.S., and will guarantee that we’ll fall behind other countries that are doing a tremendous amount of research on CRISPR techniques.

For more of this story, click here.